Video & Transcript : 'exposure claims' :

Page 19 of 500
OK

Oklahoma 2026 Regular Session

Senate Legislative Session Feb 10th, 2026

Oklahoma Senate Floor Meeting

Summary: The Senate convened, the clerk called the roll, and a quorum was declared present. The chamber opened with a prayer offered by Senator Peterson, followed by recognitions of the Nurse of the Day, Amanda Fisher, and the Doctor of the Day, Dr. Lee Schaffler, both introduced with brief biographical remarks and applause from members. The Senate also recognized the week’s pages, who introduced themselves and described their schools, assignments, and future plans. Several announcements were then made about upcoming committee and caucus meetings, including Local and County Government, Economic Development, Workforce, and Tourism, Judiciary, the first meeting of the Disability Caucus, and the start of devotion time the next morning. No legislation was debated or voted on during the session. The only formal action was adoption of a motion to adjourn, and the Senate stood adjourned until Wednesday, February 11, 2026, at 1:30 p.m.
HI

Hawaii 2025 Regular Session

CPC/CPN Joint Info Briefing - Mon Jan 27, 2025 @ 2:00 PM HST

Hawaii House Floor Meeting

Transcript Highlights:
  • </c><00:21:38.960><c> adjusting</c> billing and collection claims adjusting billing and collection claims
  • </c><00:25:52.000><c> isn't</c> value or the exposure isn't value or the exposure isn't 5050<00:25:54.120
  • </c><00:32:02.919><c> and</c> coverage to pay out all the claims and coverage to pay out all the claims
  • That's what they used to do their underwriting, policy issuance, claims, and billing.
  • What was the total payouts for claims?
Keywords: 910, house, all
HI

Hawaii 2025 Regular Session

CPC-CPN Informational Briefing 01-27-2025

Hawaii Senate Floor Meeting

Transcript Highlights:
  • What’s interesting is that the total insured value, or the exposure, isn’t 50/50.
  • </c><00:15:14.399><c> isn't</c> value or the exposure isn't value or the exposure isn't 5050<00:15:16.480
  • </c><00:21:25.240><c> and</c> coverage to pay out all the claims and coverage to pay out all the claims
  • It's a major issuance claims and billing the system issuance claims and billing the system hpia<00:26
  • What was the total payouts for claims?
Keywords: 912, senate, all
LA

Louisiana 2026 Regular Session

House of Representatives May 26th, 2026

Louisiana House Floor Meeting

Transcript Highlights:
  • “Focus on medical reimbursement system, claims data, billing, benefit administration.
  • Members, SB 465 revises Louisiana payment and claims processing laws for health insurers.
  • managers by shortening timelines for paying and adjudicating many health care claims.
  • are pended, and limits retroactive claim recoupment by insurers to 12 months.
  • It states quicker notice when claims are pended and limits retroactive claim recoupment by insurers to
Bills: HR320 , HR321 , SCR55 , SCR69 , SCR75 , SCR77 , SCR78 , SCR79 , SB259 , SB295 , SB312 , SB348 , SB444 , SB485 , HR73 , HR118 , HR144 , HR196 , HR237 , HR249 , HR260 , HR267 , HR272 , HR278 , HCR85 , HCR100 , HCR105 , HCR107 , HCR114 , HR245 , SCR5 , SCR29 , SCR33 , SCR37 , SCR63 , SCR30 , SCR40 , HB62 , HB193 , HB210 , HB220 , HB246 , HB364 , HB420 , HB475 , HB584 , HB622 , HB772 , HB784 , HB949 , HB953 , HB1043 , HB1070 , HB1092 , HB1134 , HB1162 , HB1176 , HB1196 , HB1214 , HB119 , HB129 , HB233 , HB283 , HB538 , HB789 , HB850 , HB870 , HB1236 , HB1241 , HB54 , HB137 , HB321 , HB368 , HB386 , HB414 , HB431 , HB552 , HB555 , HB578 , HB590 , HB593 , HB618 , HB638 , HB670 , HB692 , HB707 , HB708 , HB715 , HB718 , HB732 , HB741 , HB748 , HB776 , HB796 , HB807 , HB822 , HB848 , HB856 , HB887 , HB888 , HB917 , HB921 , HB1082 , HB1243 , HB1246 , HB378 , HB509 , HB1090 , HB1259 , SB80 , SB131 , SB143 , SB251 , SB254 , SB279 , SB367 , SB384 , SB388 , SB389 , SB398 , SB408 , SB431 , SB468 , SB469 , SB496 , SB4 , SB52 , SB57 , SB83 , SB145 , SB152 , SB194 , SB276 , SB319 , SB333 , SB448 , SB450 , SB465 , SB484 , SB501 , SB509 , SB149 , HR168 , HB463 , HB998 , SB123 , SB353 , SB479 , SB495 , SB82 , SB97 , SB283 , SB326 , SB518 , SB197 , SB268 , HB901 , HR20 , HR74 , HCR65 , HCR71 , HCR98 , HB284 , HB306 , HB341 , HB366 , HB393 , HB458 , HB577 , HB603 , HB605 , HB614 , HB625 , HB646 , HB733 , HB752 , HB773 , HB798 , HB911 , HB955 , HB996 , HB1035 , HB1069 , HB1113 , HB1140 , HB1180 , HB1191 , HB1240 , HB1255 , SB89 , HB74 , HB134 , HB258 , HB359 , HB468 , HB956 , HB1117 , SB29 , SB42 , SB43 , SB78 , SB208 , SB217 , SB274 , SB300 , SB341 , SB379 , SB382 , SB387 , SB401 , SB441 , SB449 , SB487
Summary: The House was called to order, a quorum was established, and the meeting opened with prayer and the Pledge of Allegiance. Members also observed several personal privileges and recognitions, including International Preeclampsia Awareness Month, the Hudson Cup award presentation to Rep. John Illg Jr., recognition of the Delcambre Shrimp Festival Queen, and a visit from U.S. Sen. John Kennedy. The chamber also received Senate messages, conference committee appointments, enrolled reports, and a conference report on SB 483 dealing with psychedelic-assisted therapy, which was laid over. The House then moved through a long series of concurrence and rejection votes on Senate amendments to House bills. Among the measures concurred in were bills affecting the Louisiana Women’s Policy Research Commission, the Louisiana Sickle Cell Commission, child exploitation reporting on covered platforms, the Children’s Cabinet Advisory Board, DCFS background checks, AI disclosure in health care, foster care placement and related terminology, criminal history record confidentiality, parish court jurisdiction, court costs, developmental disability office renaming, insurance claims and contractor licensing, Medicare Advantage coverage, colorectal cancer screening, health facilities, highway memorial designations, jury compensation, school employee protections, juvenile court fees, off-road vehicle seizure, residential property insurance cancellation, child support enforcement, and several others. The House rejected Senate amendments on bills including ethics retroactivity, sex offender registration notification, plumbers licensing, and health insurance formulary placement, sending some to conference. Several bills were finally passed, including measures on obstructing public passages with motorized vehicles, class six injection well hearings, arson of religious buildings, wearing masks while committing felonies, professional board attorney fees, bulletproof vests for peace officers, critical infrastructure protection from foreign adversaries, debit card surcharges, electronic stock certificates, watershed restoration funding, and innovation economic development pilot hubs. The innovation hub bill drew extensive debate over no-bid contracting, transparency, and the role of elected versus unelected bodies; an amendment to limit contracting authority to parish governing authorities was withdrawn, and the bill later proceeded to final passage after extended floor discussion. The House also took up and passed or concurred in multiple other bills and resolutions, with recorded votes ranging from unanimous to divided on a few measures.
LA

Louisiana 2026 Regular Session

House of Representatives May 26th, 2026

Louisiana House Floor Meeting

Transcript Highlights:
  • Focus on the medical reimbursement system, claims data, billing, benefit administration.
  • It shortens timelines for paying and adjudicating many health care claims.
  • are pended; and limits retroactive claim recoupment by insurers to 12 months.
  • managers by shortening timelines for paying and adjudicating many health care claims.
  • are pended; and limits retroactive claim recoupment by insurers to 12 months.
Bills: HR320 , HR321 , SCR55 , SCR69 , SCR75 , SCR77 , SCR78 , SCR79 , SB259 , SB295 , SB312 , SB348 , SB444 , SB485 , HR73 , HR118 , HR144 , HR196 , HR237 , HR249 , HR260 , HR267 , HR272 , HR278 , HCR85 , HCR100 , HCR105 , HCR107 , HCR114 , HR245 , SCR5 , SCR29 , SCR33 , SCR37 , SCR63 , SCR30 , SCR40 , HB62 , HB193 , HB210 , HB220 , HB246 , HB364 , HB420 , HB475 , HB584 , HB622 , HB772 , HB784 , HB949 , HB953 , HB1043 , HB1070 , HB1092 , HB1134 , HB1162 , HB1176 , HB1196 , HB1214 , HB119 , HB129 , HB233 , HB283 , HB538 , HB789 , HB850 , HB870 , HB1236 , HB1241 , HB54 , HB137 , HB321 , HB368 , HB386 , HB414 , HB431 , HB552 , HB555 , HB578 , HB590 , HB593 , HB618 , HB638 , HB670 , HB692 , HB707 , HB708 , HB715 , HB718 , HB732 , HB741 , HB748 , HB776 , HB796 , HB807 , HB822 , HB848 , HB856 , HB887 , HB888 , HB917 , HB921 , HB1082 , HB1243 , HB1246 , HB378 , HB509 , HB1090 , HB1259 , SB80 , SB131 , SB143 , SB251 , SB254 , SB279 , SB367 , SB384 , SB388 , SB389 , SB398 , SB408 , SB431 , SB468 , SB469 , SB496 , SB4 , SB52 , SB57 , SB83 , SB145 , SB152 , SB194 , SB276 , SB319 , SB333 , SB448 , SB450 , SB465 , SB484 , SB501 , SB509 , SB149 , HR168 , HB463 , HB998 , SB123 , SB353 , SB479 , SB495 , SB82 , SB97 , SB283 , SB326 , SB518 , SB197 , SB268 , HB901 , HR20 , HR74 , HCR65 , HCR71 , HCR98 , HB284 , HB306 , HB341 , HB366 , HB393 , HB458 , HB577 , HB603 , HB605 , HB614 , HB625 , HB646 , HB733 , HB752 , HB773 , HB798 , HB911 , HB955 , HB996 , HB1035 , HB1069 , HB1113 , HB1140 , HB1180 , HB1191 , HB1240 , HB1255 , SB89 , HB74 , HB134 , HB258 , HB359 , HB468 , HB956 , HB1117 , SB29 , SB42 , SB43 , SB78 , SB208 , SB217 , SB274 , SB300 , SB341 , SB379 , SB382 , SB387 , SB401 , SB441 , SB449 , SB487
TX
Transcript Highlights:
  • The exposure to China, where investments often flow through Cayman shell companies controlled by the
  • What you essentially own is a claim on a shell company that's listed in the Cayman Islands and has no
  • underlying claim on the equity of the shell company.
  • When it comes to geopolitical considerations, they claim that those factors are included in the risk
  • So from my family, it's no exaggeration for me to claim this as a matter of life and death.
Bills: HB34 , HB 128 , HB621 , HB748 , HB2259 , HB2960 , HB3113 , HB4749 , SB835 , HB128
TX

Texas 89th Regular

Senate Session (Part II) Mar 26th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • This is not an acceptable exposure under Carrier's business segments guidelines.
  • One would think they would decline to issue or. renew or cancel because of claims or because of other
  • So, we want to know how many claims did you deny, refuse to renew, or cancel?
  • The reporting is about the reason for denial, and so if we're talking about financial risk of claims,
  • This is not an acceptable exposure under carriers. business agreement guidelines.
Bills: SJR57 , SCR8 , SB8 , SB14 , SB24 , SB108 , SB112 , SB125 , SB213 , SB251 , SB315 , SB318 , SB371 , SB378 , SB379 , SB472 , SB487 , SB502 , SB513 , SB565 , SB621 , SB650 , SB689 , SB707 , SB710 , SB761 , SB763 , SB815 , SB854 , SB875 , SB896 , SB916 , SB925 , SB958 , SB961 , SB965 , SB973 , SB987 , SB990 , SB995 , SB1006 , SB1018 , SB1019 , SB1024 , SB1026 , SB1146 , SB1194 , SB1198 , SB1253 , SB1330 , SB1343 , SB1362 , SB1379 , SB1497 , SB1498 , SB1527 , SB1532 , SB1547 , SB1596 , SJR36 , SJR12 , SJR57 , SCR22 , SCR12 , SCR8 , SB565 , SB765 , SB62 , SB666 , SB707 , SB888 , SB687 , SB847 , SB1248 , SB14 , SB1006 , SB504 , SB925 , SB995 , SB857 , SB305 , SB296 , SB284 , SB815 , SB1379 , SB1497 , SB1499 , SB1498 , SB241 , SB304 , SB621 , SB1023 , SB1024 , SB686 , SB112 , SB371 , SB204 , SB609 , SB670 , SB502 , SB850 , SB854 , SB413 , SB1362 , SB1346 , SB1033 , SB1220 , SB1073 , SB810 , SB987 , SB1539 , SB447 , SB875 , SB406 , SB985 , SB965 , SB1119 , SB1505 , SB24 , SB1194 , SB1253 , SB1215 , SB1532 , SB1302 , SB856 , SB650 , SB583 , SB673 , SB213 , SB681 , SB1172 , SB1252 , SB378 , SB1343 , SB608 , SB487 , SB955 , SB957 , SB988 , SB990 , SB1019 , SB1021 , SB1120 , SB251 , SB958 , SB761 , SB541 , SB315 , SB379 , SB1018 , SB1737 , SB266 , SB1415 , SB1527 , SB125 , SB599 , SB1330 , SB53 , SB916 , SB896 , SB1352 , SB973 , SB785 , SB710 , SB472 , SB1450 , SB1502 , SB1566 , SB414 , SB1062 , SB1547 , SB961 , SB1038 , SB513 , SB578 , SB711 , SB746 , SB942 , SB1404 , SB1448 , SB1738 , SB108 , SB8 , SB318 , SB507 , SB533 , SB689 , SB1026 , SB1349 , SB1355 , SB1433 , SB1434 , SB1596 , SB1403 , SB1198 , SB1146 , SB763 , SB667 , SB1059 , SB617 , SB1567 , SB503 , SJR37 , SB16 , SB310 , SB311 , SB396 , SB505 , SB1209 , SB1210 , SB1470 , SB264 , SB924 , SB1029 , SB1185 , SB1202 , SB1358 , SB1364 , SB1569 , SB1697 , SB1376 , SB1228 , SB519 , SB878 , SB1350 , SB462 , SB1535 , SB827 , SB1585 , SB207 , SB1207 , SB1619 , SB1396 , SB920 , SB1484 , SB1273 , SB1741
AZ

Arizona 2026 Regular Session

03/23/2026 - House Health & Human Services

Health & Human Services

Transcript Highlights:
  • We're really regulated with what claims we're allowed to make.
  • Champ pointed out, misleading claims and insurers on... ...misleading claims and ensures honesty in marketing
  • Antipsychotics in a claims history from almost 10 years ago.
  • They claim to do this in order to save money.
  • They claim to do this in order to save money.
MO

Missouri 2026 Regular Session

Children and Families Feb 10th, 2026

Children and Families

Transcript Highlights:
  • We have members who, even with no claims, have been dropped from insurance.
  • We have members who, even with no claims, have been dropped from insurance.
  • So we have one example, again, and this is an organization without a claim.
  • , $20,000 claims.
  • , $20,000 claims.
Summary: The Committee on Children and Families heard public testimony on House Bills 1839, 2921, and 3015, all aimed at requiring age verification for access to online pornography. The sponsors argued the bills are needed to protect children from early exposure, exploitation, sextortion, and related harms, and said the measures mirror laws in other states and recent Texas litigation. Supporters, including the Missouri Children’s Trust Fund, pediatric sexual assault nurse examiners, child advocacy groups, the Missouri Catholic Conference, and the Attorney General’s office, testified that pornography contributes to child sexual abuse risk, addiction, and unhealthy sexual development. Committee members asked about privacy protections, enforcement, penalties, and whether third-party verification or website-based verification would be used; the Attorney General’s office said identifying information should not be retained and that enforcement would occur through court action. No one testified in opposition, and the hearing concluded with the bills remaining under consideration, with a committee substitute to follow for one portion of the legislation. The committee then heard House Bill 2610, which would use the state legal expense fund to cover claims and judgments involving foster care, case management, and residential service providers under contract with the state. Representative Murphy and supporters said the private insurance market for these providers has become unstable and unaffordable, with some agencies facing large premium increases, repeated denials, or inability to find coverage at all. Testimony from the Missouri Coalition for Children, Missouri Alliance for Children and Families, Family Forward, and the Attorney General’s office described the issue as a market failure that could force providers to close and disrupt services for foster children. The Attorney General’s office explained how legal expense fund coverage would work, noted that it can cover negligence and intentional acts for covered entities, and said the bill would shift risk to the state in the absence of adequate private insurance. No opposition was offered. Finally, Representative Terry briefly presented House Bill 24, describing it as the same as Representative Dolan’s grandparents’ bill and emphasizing that grandparents should have first consideration for custody if a child’s parents are unable to care for them. No testimony was offered on the bill. The committee then moved into executive session and voted do pass on House Committee Substitute for House Bill 1696, House Committee Substitute for House Bills 2505 and 24, and House Bill 1772, each by unanimous 14-0 votes. The meeting then adjourned.
FL

Florida 2025 Regular Session

February 19, 2025 - 09:30 AM

Transcript Highlights:
  • apply to the claim.
  • The claim accrues shall apply to the claim.
  • In our opinion, contested claims should go through the claims bill process.
  • You just authorize, legitimize the claim. I mean, the claim. I mean, the claim.
  • all these claims.
Summary: The subcommittee first heard HB 6507, a claims bill for Marcus Button, who suffered severe permanent injuries in a 2006 school bus crash. Representative Andrade explained that a jury awarded Button more than $2 million in 2009, but only a small amount was paid under sovereign immunity limits. He said Pasco County later reached a settlement with Button, but believed it lacked legal authority to pay without legislative approval. The bill would give the county that authority. There was no opposition testimony, and the bill passed unanimously, 18-0. The committee then took up HB 301, which would substantially revise Florida’s sovereign immunity framework. Representative McFarland said the bill would raise liability caps for state and local governments from $200,000/$300,000 to $1 million/$3 million, with a later increase in 2030, align statutes of limitations with private suits, allow governments to settle above the caps without a claims bill, and prevent insurance policies from conditioning payment on legislative approval. She framed the bill as a way to reduce the need for the claims bill process and provide faster redress to injured people. Testimony on HB 301 was sharply divided. Local governments, school districts, counties, cities, hospital groups, and insurance representatives opposed the bill, arguing the higher caps would sharply increase insurance and taxpayer costs, especially for small or fiscally constrained entities, and that the claims bill process and special masters provide useful review and leverage. Supporters, including the Florida Justice Association and several members, argued the current system is too slow and political, leaves seriously injured people waiting years for compensation, and should be modernized to better hold government accountable. No vote was taken on HB 301 in the portion of the meeting provided.
CA

California 2025-2026 Regular Session

Senate Health Committee Mar 25th, 2026

Transcript Highlights:
  • There is no safe level of lead exposure.
  • These were from 61 pregnancy claims dating from January... From past claims.
  • These were from 61 pregnancy claims dating from January 2023 to January 2025.
  • The resubmitted claims were...
  • My biller has then spent over 100 hours fighting each of these claims.
Summary: The Senate Committee on Health heard several health-related bills, with extensive public testimony and multiple roll-call votes. SB 895, by Senator Wiener, would create the California Foundation for Science and Health Research and place a bond measure on the November 2026 ballot to support science and health research in California amid federal funding cuts. The author and UC researchers argued the measure would protect jobs, public health, and the state’s research leadership; many universities, labor groups, and patient advocates testified in support, and there was no opposition. The committee members praised the bill, and it passed 6-0 to the Committee on Natural Resources and Water. SB 944, also by Senator Wiener, would make acupuncture a permanent Medi-Cal benefit regardless of federal matching funds. Supporters, including acupuncturists, patients, community organizations, and health access advocates, described acupuncture as effective, low-cost, and culturally important care; there was no opposition. The committee discussed access for API communities and Medi-Cal patients, and the bill passed 6-0 to the Committee on Appropriations. SB 987, by Senator Wiener, would create a California Health Access Fund to capture state savings if federal Medicaid changes cause Medi-Cal enrollment losses, with the goal of redirecting those savings to care for affected patients and providers. Support came from disability, consumer, family physician, emergency physician, psychiatric, medical, and safety-net hospital groups. Committee members discussed prioritizing indigent care, prevention, and other vulnerable populations if savings materialize. The bill passed 8-0 to Appropriations. SB 964, by Senator Smallwood-Cuevas, would limit prior authorization barriers by allowing certain dose or frequency adjustments for covered medications without repeated authorization, up to two clinically appropriate changes. The bill was supported by a Crohn’s and colitis patient and sponsor testimony describing delays in care, while health plans and insurers opposed it over safety, FDA-labeling, and cost concerns. Committee members raised questions about off-label use and clinical standards, but the author said the bill was intended to reduce delays and avoid emergency care; it passed 11-0 to Appropriations. SB 1099, by Senator Reyes, would clarify local governments’ authority to provide state and local public benefits to all residents under PRWORA-related exemptions, to reduce legal uncertainty for local safety-net programs. County counsel and city attorney representatives said the bill would preserve local flexibility to provide services such as health care, shelter, crisis response, and food distribution without unnecessary eligibility barriers; there was no opposition, and the bill passed 11-0 to the Committee on Human Services. SB 1033, by Senator Padilla, would require manufacturers of protein products to test for heavy metals and disclose results. Supporters cited Consumer Reports findings of lead, cadmium, arsenic, and mercury in protein powders and beverages, while opponents asked for narrower scope and raised concerns about naturally occurring metals and over-warning consumers. The committee discussed narrowing the bill and the need for transparency, and it passed 11-0 to the Committee on Environmental Quality. Finally, SB 1049, by Senator Weber-Pearson, would give providers a fair opportunity to correct certain claim errors after a health plan action, rather than being barred by original filing deadlines. An OBGYN testified that a missing diagnostic code led to large clawbacks and delayed payments despite appropriate care; the bill was presented as a limited fix for honest mistakes. The transcript ends during testimony on SB 1049, before a final vote is shown.
MO

Missouri 2026 Regular Session

Children and Families Feb 10th, 2026 at 08:00 am

Children and Families

Transcript Highlights:
  • Not that there was a lot of claims.
  • We have members who, even with no claims, have been dropped from insurance.
  • We have a member who has 167% increase in their premium from 2019, no claims.
  • And the claims that we have are like very minor $10,000, $20,000 claims.
  • And the claims that we have are like very minor $10,000, $20,000 claims.
Keywords: 959, house, all
MN

Minnesota 2025-2026 Regular Session

House Commerce Finance and Policy Committee 3/12/25

Commerce Finance and Policy

Transcript Highlights:
  • Is it claims? Is it liability claims?
  • Is it claims? Is it liability claims?
  • is it uh liability is it is it claims is it uh liability claims<00:48:52.960><c> I'm</c><00:48:53.119
  • Chair, members, the premiums are increasing because of the rising cost of claims.
  • </c> occurs and that can lead to more claims occurs and that can lead to more claims um<01:19:18.840>
Bills: HF1865 , HF2014 , HF2028
WA

Washington 2025-2026 Regular Session

House Civil Rights & Judiciary Jan 14th, 2026 at 08:00 am

Civil Rights & Judiciary

Transcript Highlights:
  • Generally speaking, Representative, the plaintiff has the burden of proof in a negligence claim.
  • and resolved, a subsequent claim can be presumed to be abusive.
  • and resolved, a subsequent claim can be presumed to be abusive.
  • That's the exposure for taxpayers.
  • That's the exposure for taxpayers.
Bills: HB2095
AZ

Arizona 2026 Regular Session

03/23/2026 - House Health & Human Services

House Health & Human Services Committee of Reference

Transcript Highlights:
  • I'm going to go ahead and wear lead, even though my exposure is zero.
  • We're really regulated with what claims we're allowed to make, so in the public we never make claims
  • Champ pointed out, misleading claims and insurers on... ...misleading claims and ensures honesty in marketing
  • Antipsychotics in a claims history from 10 years ago, almost.
  • They claim to do this in order to save money.
Summary: The committee heard several bills related to radiation protection in cardiac catheterization labs and later a stem cell/regenerative therapy bill. On SB 1121, which would allow hospitals with radiation protection systems to let clinicians forgo lead aprons if they work in the designated safety area and use real-time dosimetry, testimony was largely supportive or neutral after a late amendment gave radiation safety officers discretion to require protective gear if exposures approach thresholds. The committee adopted the amendment and passed SB 1121 on a 9-1 vote. SB 1120, a more prescriptive bill requiring at least 50% of cath lab rooms in hospitals to be equipped with the radiation protection system, drew divided testimony: sponsors and several physicians argued it would reduce orthopedic injury and radiation exposure and improve recruitment and retention, while hospital and radiology groups objected to the mandate, cost, limited vendor pool, and lack of clarity in the bill’s definitions. After adopting an amendment excluding children’s hospitals, the committee deadlocked 6-6 and SB 1120 failed to pass. The committee then considered SB 1118, which would appropriate $3 million to help rural hospitals install radiation protection systems in cath lab rooms. The sponsor said the funding would help rural facilities meet the same safety goals, and the committee passed the bill 6-5. The committee also heard SB 1214, a “guardrails” bill regulating non-FDA-approved stem cell and regenerative therapies, requiring informed consent, sourcing and reporting standards, advertising limits, and civil penalties for violations. Supporters said it would protect patients while allowing access to promising therapies; some members raised concerns about evidence and commercialization, but after adopting a technical amendment, the bill passed 9-3. The transcript ended as the committee moved on to SB 1630, which would seek federal approval for a home- and community-based service benefit for adults with serious mental illness; the sponsor described it as a capped, Medicaid-based community care option, and Access testified neutral while estimating a fiscal impact, but no final action on SB 1630 appears in the excerpt.
NM

New Mexico 2025 Regular Session

IC - Radioactive and Hazardous Materials Sep 2nd, 2025

Radioactive & Hazardous Materials Committee

Transcript Highlights:
  • It talks about when I was on page 40, behavior and occupational exposure.
  • So You're saying that air exposure from the dirt touching the dirt.
  • states is actual air exposure.
  • potential exposure.
  • They cannot cover those with trade secret claims, although they can use trade secret claims to hide.
AZ

Arizona 2026 Regular Session

01/29/2026 - Senate Health and Human Services

Senate Health and Human Services COR

Transcript Highlights:
  • I also talked about bringing on an external claims vendor to help... ...bringing on an external claims
  • vendor to help process claims.
  • Moving on to work on claims from January, February, March of 2024.
  • Moving on to work on claims from January, February, March of 2024.
  • the different portals that they have to submit claims through.
Summary: The committee continued its fourth hearing on fraud, waste, and abuse involving Arizona’s Medicaid and behavioral health systems, with a major focus on Access/ALTCS eligibility, behavioral health licensing, and payment delays. Senator Shamp presented findings alleging large gaps in ABD Medicaid asset verification, including that only a portion of enrollees were checked and that many with substantial liquid assets remained on the program. She argued the state’s waiver and lack of asset limits created a compliance and fiscal risk, and urged referrals to law enforcement, tighter verification, and broader reforms. Heather Dukes, representing behavioral health and sober living operators, testified that ADHS and Access have become overly punitive toward licensed providers, often sending technical paperwork violations straight to enforcement instead of allowing correction plans, and that zoning and licensing delays are harming legitimate businesses. Reva Stewart testified that patient brokering and fraudulent recruitment of vulnerable people into behavioral health and sober living settings remain ongoing, especially through social media, and called for stronger accountability and enforcement against bad actors. ADHS Deputy Assistant Director Tiffany Slater said the department has received more than a thousand complaints about unlicensed sober living operations, which has diverted staff from routine oversight of licensed facilities. She said ADHS has expanded enforcement tools for sober living homes, is using a new licensing system to flag repeat bad actors, and is trying to make the application process easier, while acknowledging that inspections can tip off unlicensed operators. Access Director Virginia Roundtree described steps the agency has taken since the prior hearing, including daily staff huddles, live dashboards, added project management support, an external claims vendor, and an independent review of the Division of Fee-for-Service Management. She said Access is trying to balance fraud prevention with support for legitimate providers, and committed to follow up on a specific provider payment dispute by early the next week. Committee members repeatedly pressed Access and ADHS on delayed claims processing, prepayment review, and whether the current system is driving providers out of business. Roundtable testimony from Access staff described the new Provider Resolution Roundtables, which are intended to work with a small number of providers facing the most claims and authorization problems. Members questioned why claims are being denied or held for long periods, why some providers are still waiting on payments from 2023 and 2024, and whether the agency’s actions are sustainable. Access also explained the Targeted Investment Program, saying it is a federally approved Medicaid initiative with large dollar amounts still being paid out on a delayed schedule, and agreed to provide more information on provider participation and payment timing. No formal votes or committee actions were taken in the portion provided, but the chair indicated the committee would continue reviewing the issue and requested additional reports and follow-up information from Access and ADHS.
CA

California 2025-2026 Regular Session

Senate Health Committee Mar 25th, 2026

Health

Transcript Highlights:
  • There is no safe level of lead exposure.
  • These were 61 pregnancy claims dating from January 2023 to January 2025.
  • Upon this discovery, our biller immediately fixed the claims and sent them back.
  • My biller has then spent over 100 hours fighting each of these claims.
  • Currently, we have 31 outstanding claims. I want to be very clear here.
Committee: Senate Health
Summary: The Senate Health Committee heard several bills focused on health care access, research funding, consumer protection, and insurance administration. SB 895 by Sen. Wiener would create the California Foundation for Science and Health Research and place a bond measure on the November 2026 ballot to support scientific and health research in California; supporters from UC, labor, and patient groups said it would protect jobs, public health, and the state’s research leadership amid federal funding cuts, while the committee later voted 6-0 to pass it as amended and re-refer it to Natural Resources and Water. SB 944 would make acupuncture a permanent Medi-Cal benefit regardless of federal matching funds; acupuncture providers, patients, health systems, and API community advocates testified in strong support, and the committee voted 6-0 to pass it as amended and re-refer it to Appropriations. The committee also considered SB 987, which would create a California Health Access Fund to capture state savings if federal Medicaid changes under H.R. 1 reduce Medi-Cal enrollment and redirect those funds to care for people who lose coverage and to reimburse safety-net providers. Support came from disability, consumer, family physician, emergency physician, hospital, and reproductive health groups; members discussed prioritizing indigent care, prevention, and safety-net needs, and the bill was moved on a unanimous vote to Appropriations. SB 964 would let a licensed provider adjust the dose or frequency of an already covered medication up to two times without prior authorization when clinically appropriate, with Crohn’s and Colitis advocates describing delays that harmed patients and insurers warning about safety and cost concerns; after committee discussion about off-label use and clinical safeguards, the bill passed 11-0 and was sent to Appropriations. Later, SB 1099 clarified local governments’ authority to provide state or local public benefits to all residents under PRWORA, with city and county counsel and local officials saying it would preserve flexibility for homeless outreach, street medicine, crisis lines, and other low-barrier services; it passed 11-0 and was re-referred to Human Services. SB 1033 would require protein product manufacturers to test for heavy metals and disclose results, prompted by Consumer Reports findings and supported by consumer, health, and women’s health groups; industry witnesses asked for narrower scope and source-level testing, and the committee voted 11-0 to pass it as amended and send it to Environmental Quality. The committee then began SB 1049, which would give providers a 90-day window after a plan’s latest action to correct certain claim errors and prevent denials based solely on missed filing deadlines; the author said it would address honest billing mistakes and recoupments, and the bill was introduced with support from medical groups and ongoing discussions with health plans.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Public Health Jun 21st, 2026 at 01:00 pm

Joint Committee on Public Health

Transcript Highlights:
  • At the top of the next screen, four down, hit RF Exposure.
  • A couple paragraphs down, they say, to reduce your exposure, basically don't touch something that is
  • And I know that the public is tired of all the technology... ...exposure.
  • The results, quote, overall exposure to high fluoride drinking water appears to...
  • Lower-level exposure has been associated with elevated TSH and hypothyroidism.
Keywords: 995, all
Summary: The Joint Committee on Public Health held a hearing focused on children’s health, disease prevention, screening, treatment, and pharmacy-related bills. The chair explained that the session was for public testimony only, with no votes or decisions taken that day, and outlined the three-minute limit for individual testimony. The committee then heard testimony on a range of bills, including H. 2413 on adding electromagnetic sensitivity to the state’s MAVEN registry, S. 1508 and H. 2433 on creating an amputation prevention task force, H. 2535 and S. 1551 on establishing a naloxone purchase trust fund, S. 1635 on authorizing pharmacists to provide opioid use disorder treatment, H. 2385 on creating a special commission on avian influenza, and S. 1497 on patient safety and non-FDA-approved compounded drugs. Testimony on H. 2413 came largely from advocates and individuals who described electromagnetic sensitivity as a real health condition and argued that adding it to the registry would improve data collection, provider education, and public awareness. Testimony on the amputation prevention task force bills came from the American Diabetes Association and podiatry groups, who said diabetes-related amputations are often preventable, disproportionately affect people of color, and could be reduced through earlier screening, better care coordination, and improved insurance coverage for preventive foot care. On the naloxone trust fund bills, a representative, emergency physician, and nurse testified that hospitals often cannot reliably send overdose patients home with naloxone because of billing and reimbursement barriers, and that a bulk-purchase fund would expand access at no added cost to payers or providers. The committee also heard strong support for S. 1635 from pharmacists and public health researchers, who said community pharmacists could safely initiate and maintain buprenorphine treatment and help close gaps in opioid use disorder care. On H. 2385, a local board of health chair supported a special commission on avian influenza, citing gaps in emergency preparedness and the need for clearer coordination across agencies. On S. 1497, a pharmacy representative opposed restrictions on compounded drugs from outsourcing facilities, warning that changes could reduce access to life-saving medications and harm patient safety. No votes or formal actions were taken during the hearing.